Verastem, Inc.: H.C. Wainwright raises target price to $20 from $18
VSTM•H.C. Wainwright raised its target price for Verastem to $20 from $18.
Related News
Delek US Holdings Q3 revenue rises, beats analyst estimates
DK•
Wells Fargo raises Sweetgreen target price to $14 from $11
SG•
Wells Fargo raises Globus Medical target price to $100 from $99
GMED•
Akamai price objective cut to $155 from $185 by BofA Global Research
AKAM•
Wendy's: Stephens raises target price to $8 from $7
WEN•